LU81300A1 - Derives d'hydantoine,procede pour leur preparation et application de ces composes comme medicaments - Google Patents

Derives d'hydantoine,procede pour leur preparation et application de ces composes comme medicaments Download PDF

Info

Publication number
LU81300A1
LU81300A1 LU81300A LU81300A LU81300A1 LU 81300 A1 LU81300 A1 LU 81300A1 LU 81300 A LU81300 A LU 81300A LU 81300 A LU81300 A LU 81300A LU 81300 A1 LU81300 A1 LU 81300A1
Authority
LU
Luxembourg
Prior art keywords
group
formula
compound
butyl
hydantoin
Prior art date
Application number
LU81300A
Other languages
English (en)
French (fr)
Inventor
W Ross
W Jamieson
R Simmonds
J Verge
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of LU81300A1 publication Critical patent/LU81300A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU81300A 1978-05-23 1979-05-22 Derives d'hydantoine,procede pour leur preparation et application de ces composes comme medicaments LU81300A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB21352/78A GB1601310A (en) 1978-05-23 1978-05-23 Aryl hydantoins
GB2135278 1978-05-23

Publications (1)

Publication Number Publication Date
LU81300A1 true LU81300A1 (fr) 1980-12-16

Family

ID=10161451

Family Applications (1)

Application Number Title Priority Date Filing Date
LU81300A LU81300A1 (fr) 1978-05-23 1979-05-22 Derives d'hydantoine,procede pour leur preparation et application de ces composes comme medicaments

Country Status (31)

Country Link
US (2) US4241073A (de)
EP (1) EP0005647B1 (de)
JP (1) JPS54160373A (de)
KR (1) KR830000635B1 (de)
AR (2) AR225143A1 (de)
AT (1) AT366034B (de)
AU (1) AU530968B2 (de)
BE (1) BE876435A (de)
BG (2) BG32115A4 (de)
CA (1) CA1120481A (de)
CH (2) CH639650A5 (de)
CS (2) CS208653B2 (de)
DD (1) DD143769A5 (de)
DE (1) DE2963061D1 (de)
DK (1) DK207579A (de)
ES (1) ES480850A1 (de)
FI (1) FI791614A (de)
FR (1) FR2426681A1 (de)
GB (1) GB1601310A (de)
GR (1) GR68363B (de)
HU (1) HU184648B (de)
IL (1) IL57343A (de)
LU (1) LU81300A1 (de)
MX (1) MX5604E (de)
NZ (1) NZ190512A (de)
PL (2) PL125075B1 (de)
PT (1) PT69648A (de)
RO (2) RO76807A (de)
SU (2) SU873878A3 (de)
YU (1) YU120179A (de)
ZA (1) ZA792501B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3013647C2 (de) * 1980-04-09 1985-07-11 Degussa Ag, 6000 Frankfurt Verfahren zur Herstellung von 5-Arylidenhydantoinen (B)
US4431656A (en) * 1981-02-05 1984-02-14 Kanegafuchi Chemical Industry Company Limited 3,5-di-Tert-butylstyrene derivatives, salts thereof, and pharmaceutical compositions containing the same as an active ingredient
US4684735A (en) * 1985-07-01 1987-08-04 Stauffer Chemical Company Promotion of raney nickel hydrogenation catalyst
JPS6317864A (ja) * 1986-07-11 1988-01-25 Mitsui Toatsu Chem Inc ヒダントイン類の製造方法
HU204047B (en) * 1987-01-31 1991-11-28 Sandoz Ag Process for producing pilocarpine derivatives and pharmaceutical compositions comprising such compounds
IE62214B1 (en) * 1988-05-25 1995-01-11 Warner Lambert Co Arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflammatory agents
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
US5362733A (en) * 1990-04-27 1994-11-08 Orion-Yhtyma Oy Pharmacologically active catechol derivatives
FR2687153B1 (fr) * 1992-02-07 1994-05-13 Hoechst Ste Francaise Procede de preparation de la (thenyl-2)-5 hydantouine.
AU2351795A (en) * 1994-04-28 1995-11-29 Yamanouchi Pharmaceutical Co., Ltd. Imidazolidinedione derivative
SE0100902D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0100903D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0103710D0 (sv) * 2001-11-07 2001-11-07 Astrazeneca Ab Compounds
KR20050044606A (ko) * 2001-11-30 2005-05-12 일라이 릴리 앤드 캄파니 퍼옥시솜 증식제에 의해 활성화된 수용체 아고니스트
SE0202539D0 (sv) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
GB0221246D0 (en) * 2002-09-13 2002-10-23 Astrazeneca Ab Compounds
FR2845000B1 (fr) * 2002-09-27 2005-05-27 Oreal Utilisation d'un compose heterocyclique ou de l'un de ses sels pour stimuler ou induire la pousse des cheveux et/ou freiner leur chute
US7648992B2 (en) 2004-07-05 2010-01-19 Astrazeneca Ab Hydantoin derivatives for the treatment of obstructive airway diseases
SE0401762D0 (sv) * 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
SE0403086D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
SE0403085D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
TW200831488A (en) * 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds
KR101542629B1 (ko) * 2007-05-30 2015-08-06 에프. 호프만-라 로슈 아게 비-뉴클레오사이드 역전사효소 억제제
EP2217573A4 (de) * 2007-11-01 2011-08-31 Uab Research Foundation Behandlung und prävention von virusinfektionen
GB2463514C (en) * 2008-09-11 2018-09-26 Galapagos Nv Imidazolidine compounds and uses therefor
ITBO20090078A1 (it) * 2009-02-13 2010-08-14 Consiglio Nazionale Ricerche Composti per il trattamento del tumore alla prostata e procedimenti per la loro sintesi

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR910275A (fr) * 1944-11-14 1946-06-03 Nouvelles hydantoïnes et leur procédé de préparation
US2479065A (en) * 1945-09-06 1949-08-16 Du Pont Preparation of 5-benzylhydantoin
US2861079A (en) * 1956-06-04 1958-11-18 Dow Chemical Co Process for making unsaturated hydantoins
GB846601A (en) * 1958-01-13 1960-08-31 British Oxygen Res And Dev Ltd Vinyl hydantoins
NL131665C (de) * 1964-05-18
US3395153A (en) * 1964-12-16 1968-07-30 United States Borax Chem 3, 5-dialkylhydantoins
US3847933A (en) * 1970-12-09 1974-11-12 Exxon Research Engineering Co Acid catalyzed alkylation of hydantoin
JPS5136332B1 (de) * 1970-12-09 1976-10-07
US3932449A (en) * 1973-10-09 1976-01-13 Morton-Norwich Products, Inc. 5-(P-dimethylaminobenzyl) hydantoin
GB1575904A (en) * 1976-04-23 1980-10-01 Lilly Industries Ltd Phenyl piperazines
JPS54122276A (en) * 1978-03-15 1979-09-21 Kanegafuchi Chem Ind Co Ltd Preparation of 5-(2-thienyl) hydantion

Also Published As

Publication number Publication date
DK207579A (da) 1979-11-24
BG32115A4 (en) 1982-05-14
US4241073A (en) 1980-12-23
SU873878A3 (ru) 1981-10-15
PL222701A1 (de) 1980-12-15
US4293563A (en) 1981-10-06
AU4728979A (en) 1979-11-29
GB1601310A (en) 1981-10-28
ES480850A1 (es) 1980-02-01
AU530968B2 (en) 1983-08-04
RO79703A (ro) 1982-08-17
CS208653B2 (en) 1981-09-15
DD143769A5 (de) 1980-09-10
FR2426681B1 (de) 1983-08-12
PT69648A (en) 1979-06-01
IL57343A (en) 1982-09-30
FR2426681A1 (fr) 1979-12-21
MX5604E (es) 1983-11-07
HU184648B (en) 1984-09-28
SU988190A3 (ru) 1983-01-07
PL119612B1 (en) 1982-01-30
FI791614A (fi) 1979-11-24
AT366034B (de) 1982-03-10
GR68363B (de) 1981-12-23
EP0005647B1 (de) 1982-06-09
DE2963061D1 (en) 1982-07-29
IL57343A0 (en) 1979-09-30
ZA792501B (en) 1980-05-28
CH643546A5 (fr) 1984-06-15
CA1120481A (en) 1982-03-23
CH639650A5 (fr) 1983-11-30
NZ190512A (en) 1984-10-19
RO76807A (ro) 1981-04-26
KR830000635B1 (ko) 1983-03-23
CS208654B2 (en) 1981-09-15
JPS54160373A (en) 1979-12-19
PL215773A1 (de) 1980-07-14
BE876435A (fr) 1979-11-21
ATA373379A (de) 1981-07-15
EP0005647A1 (de) 1979-11-28
AR224186A1 (es) 1981-10-30
YU120179A (en) 1983-02-28
BG31799A3 (en) 1982-03-15
PL125075B1 (en) 1983-03-31
AR225143A1 (es) 1982-02-26

Similar Documents

Publication Publication Date Title
LU81300A1 (fr) Derives d'hydantoine,procede pour leur preparation et application de ces composes comme medicaments
FR2665444A1 (fr) Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
LU81613A1 (fr) Nouvelles spiro-oxazolidine-diones
CA2267154A1 (fr) Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
CH640837A5 (fr) Derives de l'imidazole.
US5110831A (en) Vinylogous hydroxamic acids and derivatives thereof as 5-lipoxygenase inhibitors
CH646967A5 (fr) Composes de pyranone et compositions pharmaceutiques les comprenant.
EP0041410B1 (de) Tricyclische Äther, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0566446B1 (de) Indan-1,3-Dion und Indan-1,2,3-Trionderivate, Verfahren zu ihrer Herstellung und ihrer therapeutische Verwendung
CH646687A5 (fr) Derives de l'acide cyclohexane carboxylique.
CA2021250A1 (fr) Medicaments a base de derives de 1h-benzoxadiazine-4, 1, 2, nouveaux derives et leurs procedes de preparation
BE1004995A3 (fr) Nouveau derive de 5h-benzodiazepine, compositions pharmaceutiques le contenant et procede pour les preparer.
EP0418933A1 (de) Alkadienderivate, ihre Herstellungen und sie enthaltende Arzneimittel und Zwischenprodukte
LU81676A1 (fr) Nouveaux derives d'aurones,leur procede de preparation et leur utilisation comme produits pharmaceutiques
EP0133176B1 (de) Pharmazeutische oder veterinäre Zubereitungen zur Behandlung von ischemischen Herzstörungen
CA1139763A (fr) Procede d'obtention de nouveaux aryltrifluoroethanols
BE884387A (fr) Composition a base d'acides aryloxyalkylaminobenzoiques, leurs sels et leurs esters
CA1076117A (fr) Procede d'obtention de nouveaux ethers aryliques et les produits en resultant
EP0534856B1 (de) Thienocyclopentanonoximether, ihre Herstellung und diese enthaltende Arzneimittel
LU86706A1 (fr) Nouveaux derives du benzo(4,5)cyclohepta(1,2-b)thiophene,leur preparation et leur utilisation comme medicaments
FR2692894A1 (fr) Aryl-1-(o-alcoxy-phényl-4-pipérazinyl-1)-2, 3- ou 4-alcanols, leur procédé de préparation et leur utilisation pour la préparation de médicaments.
FR2524881A1 (fr) Nouvelles indole-alkylene-amines substituees, leur preparation et leur utilisation comme medicaments
CH627750A5 (fr) Derives de la benzophenone, procede de preparation et compositions pharmaceutiques.
FR2464251A1 (fr) Nouvelles 4-(4-cinnamoyl-1-piperidino)butyrophenones, utiles notamment comme agents antipsychotiques, et leur procede de preparation
BE849323A (fr) Derives nouveaux d'alcool benzylique et procedes pour leur preparation